Clinical Trials
1
Active:0
Completed:0
Trial Phases
1 Phases
Phase 2:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 2
1 (100.0%)Safety and Efficacy of Intravitreal Ranibizumab as a Preoperative Adjunct Treatment Before Vitrectomy Surgery in Proliferative Diabetic Retinopathy (PDR) Compared to Vitrectomy Alone
Phase 2
- Conditions
- Diabetic Retinopathy
- Interventions
- Procedure: vitrectomy without preoperative ranibizumab
- First Posted Date
- 2009-07-02
- Last Posted Date
- 2013-10-16
- Lead Sponsor
- Attila Vajas
- Target Recruit Count
- 70
- Registration Number
- NCT00931125
- Locations
- 🇭🇺
University of Debrecen, Medical and Health Science Center, Faculty of Medicine, Department of Ophthalmology, Debrecen, Hungary
News
No news found